"Look at everything—every time" is a mantra many of us have humming in the background as we go through our clinical day. Accordingly, providing screening examinations for high-risk medications, such as hydroxychloroquine, is a natural service for our profession. Plaquenil screening eye exam Plaquenil eye exam diagnosis code The American Academy of Ophthalmology released an updated set of screening recommendations for hydroxychloroquine Plaquenil and chloroquine to account for the many studies that have shown the effects of these medications on the retina 1. It succinctly makes the case for screening, and Background. The American Academy of Ophthalmology recommendations for screening of chloroquine CQ and hydroxychloroquine HCQ retinopathy were published in 2002, but improved screening tools and new knowledge about the prevalence of toxicity have appeared in the ensuing years. As patients are started on hydroxychloroquine, they will have a baseline retinal screen usually at 3 months but certainly within 12 months of starting, organised by the specialist. The specialist will also arrange a follow up retinal screen after 5 years of treatment with hydroxychloroquine. The retinopathy is hallmarked by parafoveal changes within the retina. Hydroxychloroquine is an analogue to the much older drug chloroquine. Hydroxychloroquine is most frequently used for the management of lupus and rheumatoid arthritis; however, it is now being applied to treatments in adjunctive cancer therapy, diabetes, and heart disease. Hydroxychloroquine retinopathy screening guidelines Update on Screening Recommendations for Hydroxychloroquine., Revised Recommendations on Screening for Chloroquine and. What does plaquenil deplete Abstract. Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. Recommendations on Screening for Chloroquine and Hydroxychloroquine.. Hydroxychloroquine and Retinal Screening. Hydroxychloroquine retinopathy Eye. Screening guidelines were updated this year, with some pertinent changes for our profession to note. the risk of converting to hydroxychloroquine retinopathy is 4% every year thereafter. Hydroxychloroquine retinopathy. It is the prescribing doctor’s responsibility to ensure their patients are adequately screened and to act on the results of screening. A useful aide memoir for these guidelines for hydroxychloroquine is the 5 x 5 rule ideally keep dosage 5mg/kg/day and screen after five years of drug use. Guidelines Summary The American Academy of Ophthalmology released revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy in 2016. All patients must undergo a.